Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs morphine for postoperative acute pain after abdominal surgery
CTR20211381Phase 3Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oliceridine in acute postoperative pain (2 arms), sponsored by Jiangsu Nhwa Pharmaceutical. Primary endpoint: Responder rate at 24 hours by NRS. Started Jun 2021; status: completed.
02
Drugs
oliceridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on CTR20211381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211381.